Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repare Therapeutics Inc.

1.41
-0.0300-2.08%
Volume:8.32K
Turnover:11.75K
Market Cap:60.48M
PE:-0.47
High:1.43
Open:1.40
Low:1.40
Close:1.44
Loading ...

Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics

TIPRANKS
·
07 Mar

Repare Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
04 Mar

LifeSci Capital Sticks to Its Hold Rating for Repare Therapeutics (RPTX)

TIPRANKS
·
04 Mar

Repare Therapeutics Restructures and Focuses on Key Clinical Trials

TIPRANKS
·
04 Mar

Repare Therapeutics Q4 2024 GAAP EPS $(0.67) Beats $(0.79) Estimate, $152.8M In Cash And Cash Equivalents And Marketable Securities Provides Runway To Late-2027

Benzinga
·
03 Mar

BRIEF-Repare Therapeutics FY EPS USD -2

Reuters
·
03 Mar

Repare Therapeutics Inc - Exploring Partnerships for Lunre+Camo

THOMSON REUTERS
·
03 Mar

Repare Therapeutics Inc: $152.8 Mln in Cash and Cash Equivalents and Marketable Securities Provides Runway to Late-2027

THOMSON REUTERS
·
03 Mar

Repare Therapeutics Inc: Company Reducing Its Workforce by Approximately 75%

THOMSON REUTERS
·
03 Mar

Repare Therapeutics FY Income From Operations USD -93.523 Million

THOMSON REUTERS
·
03 Mar

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
03 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Mar

LifeSci Capital Remains a Hold on Repare Therapeutics (RPTX)

TIPRANKS
·
26 Feb

Repare Therapeutics Chief Medical Officer to Leave

MT Newswires Live
·
26 Feb

Repare Therapeutics Inc - to Reduce Workforce by Approximately 75%

THOMSON REUTERS
·
25 Feb

Repare Therapeutics Inc - Expects $21 Million in Annual Operating Expense Savings

THOMSON REUTERS
·
25 Feb

Myriad Genetics (MYGN) Meets Q4 Earnings Estimates

Zacks
·
25 Feb

Catherine Wood's Strategic Reduction in Repare Therapeutics Inc Holdings

GuruFocus
·
15 Feb

Repare Therapeutics (RPTX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks
·
24 Jan

Repare Therapeutics (RPTX) Loses -5.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
21 Jan